BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11460023)

  • 1. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial.
    Richardson BA; Lavreys L; Martin HL; Stevens CE; Ngugi E; Mandaliya K; Bwayo J; Ndinya-Achola J; Kreiss JK
    Sex Transm Dis; 2001 Jul; 28(7):394-400. PubMed ID: 11460023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.
    Van Damme L; Chandeying V; Ramjee G; Rees H; Sirivongrangson P; Laga M; Perriëns J
    AIDS; 2000 Jan; 14(1):85-8. PubMed ID: 10714571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
    Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial.
    Martin HL; Stevens CE; Richardson BA; Rugamba D; Nyange PM; Mandaliya K; Ndinya-Achola J; Kreiss JK
    Sex Transm Dis; 1997 May; 24(5):279-83. PubMed ID: 9153737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa.
    Rustomjee R; Abdool Karim Q; Abdool Karim SS; Laga M; Stein Z
    AIDS; 1999 Aug; 13(12):1511-5. PubMed ID: 10465075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Tweedy KG
    JAMA; 2002 Mar; 287(9):1117-22. PubMed ID: 11879108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonoxynol-9 in lubricated condoms. Results of a study in female prostitutes.
    Ward H; De La Court A; Kitchen V
    Sex Transm Dis; 1996; 23(5):413-4. PubMed ID: 8885074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of nonoxynol-9 and changes in vaginal lactobacilli.
    Richardson BA; Martin HL; Stevens CE; Hillier SL; Mwatha AK; Chohan BH; Nyange PM; Mandaliya K; Ndinya-Achola J; Kreiss JK
    J Infect Dis; 1998 Aug; 178(2):441-5. PubMed ID: 9697724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? A meta-analysis.
    Cook RL; Rosenberg MJ
    Sex Transm Dis; 1998 Mar; 25(3):144-50. PubMed ID: 9524992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.
    Van Damme L; Niruthisard S; Atisook R; Boer K; Dally L; Laga M; Lange JM; Karam M; Perriens JH
    AIDS; 1998 Mar; 12(4):433-7. PubMed ID: 9520174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa.
    Hoffman IF; Taha TE; Padian NS; Kelly CW; Welch JD; Martinson FE; Kumwenda NI; Rosenberg ZF; Chilongozi DA; Brown JM; Chirenje M; Richardson BA
    AIDS; 2004 Nov; 18(16):2191-5. PubMed ID: 15577653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
    Amaral E; Faúndes A; Zaneveld L; Waller D; Garg S
    Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's up with nonoxynol-9?
    Forbes A; Heise L
    Reprod Health Matters; 2000 Nov; 8(16):156-9. PubMed ID: 11424245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of nonoxynol-9-containing spermicides on urogenital infection.
    McGroarty JA; Reid G; Bruce AW
    J Urol; 1994 Sep; 152(3):831-3. PubMed ID: 8051730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.
    Kreiss J; Ngugi E; Holmes K; Ndinya-Achola J; Waiyaki P; Roberts PL; Ruminjo I; Sajabi R; Kimata J; Fleming TR
    JAMA; 1992 Jul 22-29; 268(4):477-82. PubMed ID: 1320133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial.
    Kaul R; Kimani J; Nagelkerke NJ; Fonck K; Ngugi EN; Keli F; MacDonald KS; Maclean IW; Bwayo JJ; Temmerman M; Ronald AR; Moses S;
    JAMA; 2004 Jun; 291(21):2555-62. PubMed ID: 15173146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections.
    Louv WC; Austin H; Alexander WJ; Stagno S; Cheeks J
    J Infect Dis; 1988 Sep; 158(3):518-23. PubMed ID: 2842403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: barrier protection against HIV infection and other sexually transmitted diseases.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Aug; 42(30):589-91, 597. PubMed ID: 8336689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India.
    Joshi S; Joglekar N; Ghate M; Unni J; Risbud A; Bentley M; Shepherd M; Bollinger R; Mehendale S
    Indian J Med Res; 2003 Apr; 117():152-7. PubMed ID: 14604303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.